S
MGRM

SignatureFD’s Monogram Orthopaedics MGRM Stock Holding History

SignatureFD’s Portfolio MGRM Stock Details MGRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-266
Closed -$782 – 3361
2025
Q1 		$782 Hold
266
– – ﹤0.01% 3096
2024
Q4 		$630 Sell
266
-300
-53% -$703 ﹤0.01% 3110
2024
Q3 		$1.5K Buy
566
+300
+113% +$781 ﹤0.01% 2906
2024
Q2 		$572 Hold
266
– – ﹤0.01% 2971
2024
Q1 		$649 Hold
266
– – ﹤0.01% 3002
2023
Q4 		$915 Hold
266
– – ﹤0.01% 2919
2023
Q3 		$692 Buy
+266
New +$1.12K ﹤0.01% 2983

Other funds holding MGRM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $11.8B AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SignatureFD's MGRM Position: Q2 2025 in Review

SignatureFD sold out of Monogram Orthopaedics (MGRM) in Q2 2025, closing a stake of 266 shares — an estimated $782 sold.

SignatureFD first reported a position in MGRM in Q3 2023 and held it in 7 quarters. The position peaked at $1.5K in Q3 2024. 49 funds tracked by Wall St. Rank hold MGRM as of Q2 2025.

  • SignatureFD reported no remaining Monogram Orthopaedics position as of Q2 2025 after selling out during the quarter.
  • SignatureFD sold 266 Monogram Orthopaedics shares in Q2 2025, an estimated $782.
  • SignatureFD first reported a position in Monogram Orthopaedics in Q3 2023 and held it in 7 quarters.
  • SignatureFD's Monogram Orthopaedics position peaked at $1.5K in Q3 2024.
  • 49 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q2 2025.

Based on SignatureFD's 13F filing for Q2 2025, filed 16 Jul 2025.